drugset
Drugs / Autologous peripheral blood CD34 positive cell therapy
last change Sep 2009 re-read 3 minutes ago

Autologous peripheral blood CD34 positive cell therapy

Cell therapy

Developed for
myocardial ischemia · coronary artery disorder
Investigated by
Foundation for Biomedical Research and Innovation · Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan · Kobe City General Hospital · Okayama University School of Medicine

Trials 1

today NCT00221182 · Ph 1/2
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT00221182 Sep 2005 → Sep 2009 intermediate coronary syndrome, myocardial infarction, myocardial ischemia Foundation for Biomedical Research and Innovation Terminated No outcome recorded Stop: Enrollment

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous peripheral blood CD34 positive cell therapy ClinicalTrials.gov intervention name — accepted as the source's own label NCT00221182 ↗
Modality Cell therapy “stem cell therapy with your own cells (autologous cells)” NCT00221182 ↗
Route Other “delivered with a catheter to regions of the heart with poor blood flow” NCT00221182 ↗